In April 2025, MoHFW revised the NPRD 2021 equipment list via DGHS notification, removing brand-specific references and restoring a level playing field for all qualified vendors.
Established the principle of platform-agnostic procurement in rare disease diagnostics. Ensures procurement decisions are driven by clinical capability rather than incumbent specification.